Incrementha PD&I

Incrementha PD&I is a Brazilian pharmaceutical research and development company established as a joint venture between two leading national laboratories, Eurofarma and Biolab Sanus. Founded in 2006 and headquartered at the CIETEC incubator at the University of São Paulo, the company focuses on incremental innovation, including new drug delivery systems, fixed-dose combinations, and nanotechnology-based formulations. Notable achievements include the development of Brazil's first nanodrug, a topical anesthetic, and the licensing of insulin eye drops for treating severe dry eye. Incrementha serves as a strategic R&D arm for its parent companies, bridging the gap between academic research and industrial production to bring innovative therapies to the Brazilian market.